Plasma levels of soluble interleukin 1 receptor accessory protein are reduced in obesity
MetadataShow full item record
Context: Adipokines actuate chronic, low-grade inflammation through a complex network of immune markers, but the current understanding of these networks is incomplete. The soluble isoform of the IL-1 receptor accessory protein (sIL1RAP) occupies an important position in the inflammatory pathways involved in obesity. The pathogenetic and clinical influences of sIL1RAP are unknown. Objective: The objective of the study was to elucidate whether plasma levels of sIL1RAP are reduced in obesity, using affluent clinical, biochemical, and genetic data from two diverse cohorts. Design, Setting, and Participants: The study was conducted in two cohorts: the San Antonio Family Heart Study (n = 1397 individuals from 42 families) and South Asians living in Mauritius, n = 230). Main Outcome Measures: Plasma sIL1RAP levels were measured using an ELISA. The genetic basis of sIL1RAP levels were investigated using both a large-scale gene expression profiling study and a genome-wide association study. Results: A significant decrease in plasma sIL1RAP levels were observed in obese subjects, even after adjustment for age and sex. The sIL1RAP levels demonstrated a strong inverse association with obesity measures in both populations. All associations were more significant in females. Plasma sIL1RAP levels were significantly heritable, correlated with IL1RAP transcript levels (NM_134470), showed evidence for shared genetic influences with obesity measures and were significantly associated with the rs2885373 single-nucleotide polymorphism (P = 6.7 × 10−23) within the IL1RAP gene. Conclusions: Plasma sIL1RAP levels are reduced in obesity and can potentially act as biomarkers of obesity. Mechanistic studies are required to understand the exact contribution of sIL1RAP to the pathogenesis of obesity. - See more at: http://press.endocrine.org/doi/abs/10.1210/jc.2013-4475#sthash.l34avYkY.dpuf
Showing items related by title, author, creator and subject.
Differential nitric oxide levels in the blood and skeletal muscle of Type 2 diabetic subjects may be consequence of adiposity: a preliminary study.Krause, M.; Rodrigues-Krause, J.; O'Hagan, C.; De Vito, G.; Boreham, C.; Susta, D.; Newsholme, Philip; Murphy, C. (2012)Background and Aims: Nitric oxide (NO) exerts key regulatory functions including vasodilation and glucose uptake. Thus reduced NO levels are associated with insulin resistance and hypertension. In this preliminary work ...
Bozaoglu, K.; Curran, J.; Stocker, C.; Zaibi, M.; Segal, D.; Konstantopoulos, N.; Morrison, S.; Carless, M.; Dyer, T.; Cole, S.; Goring, H.; Moses, Eric; Walder, K.; Cawthorne, M.; Blangero, J.; Jowett, J. (2010)Context: Chemerin is a new adipokine associated with obesity and the metabolic syndrome. Gene expression levels of chemerin were elevated in the adipose depots of obese compared with lean animals and was markedly elevated ...
Healy, Genevieve; Dunstan, D.; Salmon, J.; Shaw, J.; Zimmet, P.; Owen, N. (2008)PURPOSE: Among Australian adults who met the public health guideline for the minimum health-enhancing levels of physical activity, we examined the dose-response associations of television-viewing time with continuous ...